The Food and Drug Administration Pulls Zantac From Pharmacy Shelves

Earlier this week, the U.S. Food and Drug Administration issued a  news release  requesting manufacturers to withdraw all products containing the popular heartburn drug, ranitidine, the active ingredient in the medication, Zantac . The order applies to both prescription and over-the-counter medications.

The recent recall is the latest step in an escalating investigation surrounding a contaminant known as N-Nitrosodimethylamine (NDMA), which is commonly found in ranitidine.

NDMA is listed as a well-known human carcinogen. At high levels, the substance can be very dangerous and life-threatening.